CN115414423A - Traditional Chinese medicine composition for treating eczema and application of traditional Chinese medicine composition in preparation of itching-relieving and healing-promoting cream - Google Patents

Traditional Chinese medicine composition for treating eczema and application of traditional Chinese medicine composition in preparation of itching-relieving and healing-promoting cream Download PDF

Info

Publication number
CN115414423A
CN115414423A CN202211173707.3A CN202211173707A CN115414423A CN 115414423 A CN115414423 A CN 115414423A CN 202211173707 A CN202211173707 A CN 202211173707A CN 115414423 A CN115414423 A CN 115414423A
Authority
CN
China
Prior art keywords
parts
chinese medicine
traditional chinese
medicine composition
relieving
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN202211173707.3A
Other languages
Chinese (zh)
Other versions
CN115414423B (en
Inventor
杨延龙
陈婷如
丁卢颖
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Second Military Medical University SMMU
Original Assignee
Second Military Medical University SMMU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Second Military Medical University SMMU filed Critical Second Military Medical University SMMU
Priority to CN202211173707.3A priority Critical patent/CN115414423B/en
Publication of CN115414423A publication Critical patent/CN115414423A/en
Application granted granted Critical
Publication of CN115414423B publication Critical patent/CN115414423B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13Coniferophyta (gymnosperms)
    • A61K36/15Pinaceae (Pine family), e.g. pine or cedar
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/234Cnidium (snowparsley)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/238Saposhnikovia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/282Artemisia, e.g. wormwood or sagebrush
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/287Chrysanthemum, e.g. daisy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/32Burseraceae (Frankincense family)
    • A61K36/328Commiphora, e.g. mecca myrrh or balm of Gilead
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/532Agastache, e.g. giant hyssop
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/534Mentha (mint)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/538Schizonepeta
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/739Sanguisorba (burnet)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/75Rutaceae (Rue family)
    • A61K36/756Phellodendron, e.g. corktree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a traditional Chinese medicine composition for treating eczema, which is prepared from the following components in parts by weight: 5 to 15 parts of golden larch bark, 5 to 15 parts of wild chrysanthemum flower, 5 to 15 parts of garden burnet root, 5 to 15 parts of wrinkled gianthyssop herb, 5 to 15 parts of oriental wormwood, 4 to 10 parts of fineleaf schizonepeta herb, 3 to 8 parts of divaricate saposhnikovia root, 3 to 8 parts of common cnidium fruit, 3 to 8 parts of mint, 1 to 5 parts of amur corktree bark, 1 to 5 parts of myrrh and 3 to 8 parts of liquorice. The itching-relieving and healing-promoting cream preparation is suitable for treating acute, subacute and chronic eczema, has good curative effect, obviously improves erythema, desquamation, lichenification and pruritus of an eczema mouse, can reduce the thickness of the skin of the mouse, reduces the serum IgE level of the mouse and has no obvious adverse reaction.

Description

Traditional Chinese medicine composition for treating eczema and application of traditional Chinese medicine composition in preparation of itching-relieving and healing-promoting cream
Technical Field
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine composition for treating eczema and application of the traditional Chinese medicine composition in preparation of an itching-relieving and healing-promoting cream.
Background
Eczema (AD) is an inflammatory reaction of skin with severe pruritus caused by various internal and external factors, and with the continuous improvement of the etiology and mechanism thereof in recent years, scholars at home and abroad divide the skin into atopic dermatitis, contact dermatitis and the like. Eczema tends to exude in the acute stage and infiltrates and is hypertrophic in the chronic stage. The skin lesion has the characteristics of polymorphism, symmetry, pruritus, easy repeated attack and the like. The incidence of eczema is on the rise year by year in our country, with the incidence of childhood ranging from 0.7% in 1998 to 12.94% in 2014 (Gu Heng, yan Yan, chen, etc. national atopic dermatitis epidemiological investigation [ J ] Chinese journal of dermatology, 2000,33 (6): 4.; guo Y, li P, tang J, et al. Its pathogenesis is also influenced by various environmental and genetic factors, of which the skin barrier dysfunction and immune dysfunction are the main pathological conditions, which cause repeated inflammation and itching of the skin. AD is known to be primarily immune system dysfunction and environmental factors damaging the skin barrier, exacerbating immunoglobulin E (IgE) -mediated sensitization, severe skin inflammation and immune responses (Giustizieri M L, mascia F, frezzolini A, et al. Keratino microorganisms from tissues with atomic resolution and ps show a diagnosis of chemotherapy process profile in response to T cell-derived cytokines. [ J ]. J Allergy Clin immune, 2001,107 (5): 871-877.).
According to the Chinese guideline for diagnosis and treatment of atopic dermatitis (2020 version) (immunological group of the dermatological society of the Chinese medical society, center for cooperative research on atopic dermatitis, chinese guideline for diagnosis and treatment of atopic dermatitis (2020 version) [ J ]. Chinese journal of dermatology, 2020,053 (002): 81-88.), the purpose of treating AD is to alleviate or eliminate clinical symptoms, reduce and prevent recurrence, improve the quality of life of patients, and enable patients to enjoy normal life. In short, the therapeutic goal of AD is to maintain remission. Therefore, timely and effective reduction of inflammation is a primary goal of treatment.
Existing topical basic anti-inflammatory treatments for eczema include glucocorticoids (TCS), calcineurin inhibitors (TCI) and JAK inhibitors (Mehta a, nadkarni N, patil S, et al. Topical dermatological in informatics [ J ]. Indian Journal of dermatological surgery and Leprology, 8978 zft 8978 (4): 1093-105.). TCS, while effective in controlling inflammation, is susceptible to recurrent attacks of AD, and prolonged use can result in dry, atrophic, hyperpigmented epidermis, and even aggravated infection (Siegfried E C, jaworski J C, kaiser J D, et al. Systematic review of published tertiary; long-term safety of topical cosmetic and topical cosmetic inhibitors in topical patients with topical efficacy of topical cosmetic derivatives [ J ]. Bmc plaques, 2016,16 (1): 75. Systematic E C, jaworski J C, kaiser J D, et al. Systematic review of topical cosmetic derivatives [ J ]. 3262. Biological inhibitors [ B.1.: 3262. Biological salts of topical cosmetic inhibitors [ J ]. 62. Biological inhibitors of topical cosmetic inhibitors [ J ]. 1. Biological inhibitors of topical cosmetic inhibitors of topical drugs, and topical drugs of topical drugs [ 1. Biological inhibitors of topical drugs, 3262. In the present application of topical cosmetic inhibitors [ B.. TCI, while not causing atrophy of the skin, is locally irritating and causes itching, and some patients are intolerant (Piotr, ciechanowicz, adriana, et al jak-inhibitors of current opinion and future applications [ J ] Journal of Dermatological Treatment, 2018). The topical JAK inhibitors can inhibit skin inflammation and improve skin barrier function, but may cause skin infections such as folliculitis, acne, kaposi's spot rash and herpes simplex (2 am, tabassum s. Cyclosporine in dermatology.
In cases where topical anti-inflammatory drugs are not palliative, systemic therapeutic drugs should be used in combination, including the use of oral antihistamines, immunosuppressants, oral TCS, and biologies. Oral antihistamines can relieve itching in patients, but are less effective and therefore are only adjunctive therapy; immunosuppressive agents such as cyclosporin inhibit interleukins and relieve itching, but they are nephrotoxic and induce hypertension and hyperlipidemia, and thus they are not used for more than 1 year (Yu, sherry, H, et al. A systematic review of the safety and efficacy of systematic microbiological agents in atomic disorders [ J]Journal of the American Academy of Dermatology, 2018.); oral TCS can be used for a short time for acute exacerbations or severe lesions, but it is systemicGreat adverse reactions (
Figure BDA0003864501370000021
M,Srour J,Walter A,Knop M,Wollenberg A.Dupilumab for treatment of atopic dermatitis[J].Expert Rev Clin Pharmacol.2018,11(5):467-474.)。
Eczema is often treated in a non-persistent manner due to the long course of eczema, easy recurrence, inconvenient treatment, side effects, lack of trust in doctors and the like (Yang Z, liu M, wang W, et al. Pseudolaric acid B injuries and patient pain dermatitis-like skin lesions by inhibiting the invasion of interstitial-17-induced inflammation [ J ] Rep,2017,7 (1): 7918.). Therefore, the medicine which is effective, has low side effect and is convenient to use is selected, the compliance of patients can be greatly improved, the curative effect is improved, the existing medicines are difficult to simultaneously meet the three points and can be used for a long time, and the traditional Chinese medicine treatment has unique advantages in this aspect. AD belongs to the categories of eczema, blood-wind sore, acute eczema, scrofula and the like in traditional Chinese medicine. Modern Chinese medicine summarizes the pathogenesis of the disease as body deficiency, the pathogenic wind-damp heat as the target, and the disease is considered to be caused by the intrinsic deficiency and the exogenous pathogenic wind-damp heat, which cause the accumulation of wind-damp heat in the body and the invasion of skin.
The external medicine formula principle for clinically treating eczema is mainly to expel wind, dampness and heat evil, is assisted by killing parasites to relieve itching, and is used for detoxifying and promoting granulation of skin with scratching and ulceration.
Disclosure of Invention
The first purpose of the invention is to provide a traditional Chinese medicine composition for treating eczema.
The second purpose of the invention is to provide the application of the traditional Chinese medicine composition for treating eczema in preparing the cream for relieving itching and promoting healing.
In order to achieve the purpose, the technical scheme adopted by the invention is as follows:
the invention provides a traditional Chinese medicine composition for treating eczema, which is prepared from the following components in parts by weight: 5 to 15 parts of golden larch bark, 5 to 15 parts of wild chrysanthemum flower, 5 to 15 parts of garden burnet root, 5 to 15 parts of wrinkled gianthyssop herb, 5 to 15 parts of oriental wormwood, 4 to 10 parts of fineleaf schizonepeta herb, 3 to 8 parts of divaricate saposhnikovia root, 3 to 8 parts of common cnidium fruit, 3 to 8 parts of mint, 1 to 5 parts of amur corktree bark, 1 to 5 parts of myrrh and 3 to 8 parts of liquorice.
The traditional Chinese medicine composition for treating eczema is prepared from the following components in parts by weight: 10 parts of golden larch bark, 10 parts of wild chrysanthemum flower, 10 parts of carbonized sanguisorba root, 10 parts of wrinkled gianthyssop herb, 10 parts of oriental wormwood, 7 parts of fineleaf schizonepeta herb, 5 parts of divaricate saposhnikovia root, 5 parts of common cnidium fruit, 5 parts of mint, 3 parts of golden cypress, 3 parts of myrrh and 5 parts of liquorice.
The traditional Chinese medicine composition for treating eczema is prepared from the following components in parts by weight: 15 parts of golden larch bark, 5 parts of wild chrysanthemum flower, 15 parts of carbonized sanguisorba root, 15 parts of wrinkled gianthyssop herb, 15 parts of oriental wormwood, 10 parts of fineleaf schizonepeta herb, 8 parts of divaricate saposhnikovia root, 8 parts of common cnidium fruit, 8 parts of mint, 5 parts of amur corktree bark, 5 parts of myrrh and 8 parts of liquorice.
The traditional Chinese medicine composition for treating eczema is prepared from the following components in parts by weight: 5 parts of golden larch bark, 15 parts of wild chrysanthemum flower, 5 parts of carbonized sanguisorba root, 5 parts of wrinkled gianthyssop herb, 5 parts of oriental wormwood, 4 parts of fineleaf schizonepeta herb, 3 parts of divaricate saposhnikovia root, 3 parts of common cnidium fruit, 3 parts of mint, 2 parts of amur corktree bark, 2 parts of myrrh and 3 parts of liquorice.
In the traditional Chinese medicine composition for treating eczema, the monarch drug is golden larch bark, and the ministerial drugs are fructus cnidii, wild chrysanthemum, wrinkled gianthyssop and mint; the adjuvant materials include herba Artemisiae Scopariae, herba Schizonepetae, radix Saposhnikoviae, charred radix Sangusorbae, cortex Phellodendri, and Myrrha; the guiding drug is licorice.
The nature, taste, meridian tropism and function of each medicine in the formula and the common dosage are as follows:
golden larch bark: nature and taste: pungent and warm; is toxic. Meridian tropism: it enters lung and spleen meridians. Function: kill parasites and relieve itching. The dosage is as follows: proper dosage is for external application.
Wild chrysanthemum: nature and taste: bitter, pungent and slightly cold. Meridian tropism: it enters liver and heart meridians. Function: clearing away heat and toxic material. The dosage is as follows: proper dosage is for external application.
Charring the garden burnet root: nature and taste: bitter, sour, astringent and slightly cold. Meridian tropism: it enters liver and large intestine meridians. The functions are as follows: cool blood and stop bleeding, remove toxicity and heal wound. The dosage is as follows: proper dosage is for external application.
Agastache rugosus: property and taste: pungent and warm. Meridian tropism: it enters lung, spleen and stomach meridians. The functions are as follows: regulate the middle warmer, remove dirt and dampness. The dosage is as follows: proper dosage is for external application.
Herba artemisiae scopariae: property and taste: bitter, pungent and slightly cold. Meridian tropism: it is also found in the spleen, stomach, liver and gallbladder meridians. The functions are as follows: clear damp-heat and alleviate jaundice. The dosage is as follows: proper dosage is for external application.
Herba schizonepetae: nature and taste: pungent and warm. Meridian tropism: it enters lung and liver meridians. The functions are as follows: relieve exterior syndrome, dispel wind and promote eruption. The dosage is as follows: proper dosage is for external application.
Wind prevention: nature and taste: pungent, sweet and warm. Meridian tropism: it enters bladder, liver and spleen meridians. The functions are as follows: relieving exterior syndrome, dispelling pathogenic wind, and eliminating dampness. The dosage is as follows: proper dosage is for external application.
Fructus cnidii: property and taste: pungent, bitter and warm; has little toxicity. Meridian tropism: it enters kidney meridian. The functions are as follows: dry dampness, dispel wind, kill parasites. The dosage is as follows: proper dosage is for external application.
Mint: nature and taste: pungent and cool. Meridian tropism: it enters lung and liver meridians. The functions are as follows: disperse wind-heat. The dosage is as follows: proper dosage is for external application.
Phellodendron bark: nature and taste: bitter and cold. It enters kidney and bladder meridians. Function: clear heat and dry dampness, remove toxicity and cure sore. The dosage is as follows: proper dosage is for external application.
Myrrh: nature and taste: bitter and neutral. Meridian tropism: enter liver meridian. The functions are as follows: disperse blood and remove stasis, relieve swelling and alleviate pain. The dosage is as follows: proper dosage is for external application.
Licorice root: nature and taste: sweet and neutral. Meridian tropism: it enters heart, lung, spleen and stomach meridians. Function: clear heat and remove toxicity, and harmonize the recipe. The dosage is as follows: proper dosage is for external application.
In the formula, the golden larch bark and the common cnidium fruit are used for dispelling wind, killing parasites and relieving itching, the wild chrysanthemum flower and the garden burnet root are used for clearing heat and removing toxicity, the oriental wormwood, the golden cypress and the wrinkled gianthyssop herb are used for clearing heat, drying dampness and killing parasites, the fineleaf schizonepeta herb, the divaricate saposhnikovia root and the mint are used for clearing heat, relieving exterior syndrome and dispelling wind, the myrrh is used for detumescence and promoting granulation, and the liquorice is used for relieving the drug toxicity. The medicines are mixed to play the effects of clearing heat, dispelling wind, removing dampness, killing parasites and relieving itching.
The second aspect of the invention provides application of the traditional Chinese medicine composition for treating eczema in preparation of an itching-relieving and healing-promoting cream.
The preparation method of the itching-relieving and healing-promoting cream comprises the following steps:
firstly, mixing golden larch bark, wild chrysanthemum flower, carbonized sanguisorba root, wrinkled gianthyssop herb, oriental wormwood, fineleaf schizonepeta herb, divaricate saposhnikovia root, common cnidium fruit, mint, amur corktree bark, myrrh and liquoric root according to a ratio, adding 8-12 (preferably 12) times of distilled water, decocting for 1-3 (preferably 2) times, 1-2 (preferably 2) hours each time, and combining water extracts for the next step; obtaining the volatile oil of the medicinal materials;
step two, filtering the water extract obtained in the previous step to be clear, adding 80% ethanol until the alcohol concentration in the water extract reaches a preset value, standing overnight at 4 ℃, filtering, and concentrating under reduced pressure distillation until no alcohol smell exists to obtain an alcohol precipitation water extract;
thirdly, the formula of the itching-relieving and healing-promoting cream is as follows: oil phase: 15 to 22g of stearic acid, 6 to 10g of glycerin monostearate, 25 to 35g of liquid paraffin, 8 to 12g of vaseline and 0.5 to 1g of the medicinal material volatile oil prepared in the first step; water phase: 4-8 g of triethanolamine, 25-35 g of glycerol and 180-210 g of alcohol precipitation water extract prepared in the second step;
according to the dosage of each component, the oil phase and the water phase are respectively mixed, the mixture is heated to be liquefied under the condition that the temperature is 75-85 ℃ (preferably 80 ℃), the two phases are mixed while the mixture is hot, the mixture is stirred for 10-15min, and the mixture is cooled to obtain the cream for relieving itching and promoting healing.
Preferably, the formula of the itching-relieving and healing-promoting cream comprises the following components: oil phase: 18g of stearic acid, 8.1g of glyceryl monostearate, 32.1g of liquid paraffin, 9.9g of vaseline and 0.75g of the medicinal material volatile oil prepared in the first step; water phase: 6g of triethanolamine, 30g of glycerol and 8978 g of the alcohol precipitation water extract prepared in the second step.
Due to the adoption of the technical scheme, the invention has the following advantages and beneficial effects:
in the traditional Chinese medicine composition, the golden larch bark and the common cnidium fruit are used for dispelling wind, killing parasites and relieving itching, the wild chrysanthemum flower and the garden burnet root are used for clearing heat and removing toxicity, the oriental wormwood, the golden cypress and the wrinkled gianthyssop are used for clearing heat, drying dampness and killing parasites, the schizonepeta, the divaricate saposhnikovia root and the mint are used for clearing heat, relieving exterior syndrome and dispelling wind, the myrrh is used for reducing swelling and promoting granulation, and the liquorice is used for relieving the toxicity of the medicine. The medicines are mixed to play the efficacies of clearing heat, dispelling wind, eliminating dampness, killing parasites and relieving itching.
The itching-relieving and healing-promoting cream preparation is suitable for treating acute, subacute and chronic eczema, has good curative effect, obviously improves erythema, desquamation, lichenification and pruritus of an eczema mouse, can reduce the thickness of the skin of the mouse, reduces the serum IgE level of the mouse and has no obvious adverse reaction.
Drawings
FIG. 1 is a schematic representation of skin lesion expression in each group of mice.
FIG. 2 is a schematic representation of pathological sections of mice in each group.
Detailed Description
In order to more clearly illustrate the invention, the invention is further described below in connection with preferred embodiments. It is to be understood by persons skilled in the art that the following detailed description is illustrative and not restrictive, and is not to be taken as limiting the scope of the invention.
Example 1
A traditional Chinese medicine composition for treating eczema is prepared from the following components in parts by weight: 10g of golden larch bark, 10g of wild chrysanthemum flower, 10g of carbonized sanguisorba root, 10g of wrinkled gianthyssop herb, 10g of oriental wormwood, 7g of fineleaf schizonepeta herb, 5g of divaricate saposhnikovia root, 5g of common cnidium fruit, 5g of mint, 3g of amur corktree bark, 3g of myrrh and 5g of liquorice.
The preparation method of the Chinese medicinal composition decoction comprises the following steps:
decocting in water for 2 times, adding 960mL of water for the first time, and decocting for 180min to obtain a first decoction; adding water to 960mL for the second time (including residue of the first decoction), and decocting for 180min to obtain a second decoction; combining the first and second decoctions to obtain a water decoction.
Example 2
A traditional Chinese medicine composition for treating eczema is prepared from the following components in parts by weight: 15g of golden larch bark, 5g of wild chrysanthemum flower, 15g of carbonized sanguisorba root, 15g of wrinkled gianthyssop herb, 15g of oriental wormwood, 10g of fineleaf schizonepeta herb, 8g of divaricate saposhnikovia root, 8g of common cnidium fruit, 8g of mint, 5g of amur corktree bark, 5g of myrrh and 8g of liquorice.
Example 3
A traditional Chinese medicine composition for treating eczema is prepared from the following components in parts by weight: 5g of golden larch bark, 15g of wild chrysanthemum flower, 5g of carbonized sanguisorba root, 5g of wrinkled gianthyssop herb, 5g of oriental wormwood, 4g of fineleaf schizonepeta herb, 3g of divaricate saposhnikovia root, 3g of common cnidium fruit, 3g of mint, 2g of amur corktree bark, 2g of myrrh and 3g of liquorice.
Example 4
1. The preparation method of the itching-relieving and healing-promoting cream comprises the following steps:
weighing 10g of golden larch bark, 10g of wild chrysanthemum flower, 10g of carbonized sanguisorba root, 10g of wrinkled gianthyssop herb, 10g of oriental wormwood, 7g of fineleaf schizonepeta herb, 5g of divaricate saposhnikovia root, 5g of common cnidium fruit, 5g of mint, 3g of amur corktree bark, 3g of myrrh and 5g of liquorice, and totally 80g. Three for designing water adding quantity, decocting time and decocting timesFactor, three-level orthogonal test, plotting L 9 (3 4 ) Orthogonal table (as shown in table 1), optimizes the extraction process of the cream for relieving itching and promoting healing, and finally obtains the extract with 12 times of distilled water, decocting for 2 times, the extract with the highest score after 3 hours every time, according to the extract yield (extract yield = dry powder (g)/total amount of medicinal materials (g) × 100%) obtained by drying water extract in an evaporation dish after concentrating and the content comprehensive score of three effective components of chlorogenic acid, golden larch bark acetic acid and osthole, which is shown in table 2.
TABLE 1 orthogonal test factor horizon
Figure BDA0003864501370000061
TABLE 2 extraction of antipruritic and healing promoting extract L 9 (3 4 ) Orthogonal table design and results
Figure BDA0003864501370000062
The optimal method comprises the following steps: mixing cortex pseudolaricis 10g, flos Chrysanthemi Indici 10g, charred radix Sangusorbae 10g, herba Agastaches 10g, herba Artemisiae Scopariae 10g, herba Schizonepetae 7g, radix Saposhnikoviae 5g, fructus Cnidii 5g, herba Menthae 5g, cortex Phellodendri 3g, myrrha 3g, and Glycyrrhrizae radix 5g, and mixing to total 80g. Adding 12 times of distilled water, decocting for 2 times, each time for 2 hours, and mixing the water extracts to obtain 1200mL for the next step; and obtaining 0.6ml of medicinal material volatile oil.
2. Optimization of alcohol precipitation process of itching-relieving and healing-promoting cream
Filtering 1200mL of the water extract obtained in the last step until the water extract is clear, performing an alcohol precipitation test, and setting the alcohol precipitation concentration as a study factor, wherein the three levels are respectively set to be 60%, 70% and 80%. Adding ethanol until the ethanol concentration in the water extract reaches a preset value, transferring to a refrigerator, and standing at 4 deg.C overnight. Filtering the water extract after alcohol precipitation, observing that 60 percent and 70 percent alcohol precipitation are carried out, and observing that the precipitate is less than 80 percent, considering that the cream for relieving itching and promoting healing needs transdermal absorption to play a role, carrying out alcohol precipitation by 80 percent concentration. Concentrating the ethanol precipitation solution by vacuum distillation until no alcohol smell is observed, and measuring the densityIs 1.006g/cm 3 . The extract is used as water phase, and is stored in a refrigerator at 4 ℃ for later use.
The optimal method comprises the following steps: filtering 1200mL of the water extract obtained in the last step to be clear, adding 80% ethanol until the alcohol concentration in the water extract reaches a preset value, standing overnight at 4 ℃, filtering, distilling and concentrating under reduced pressure until no alcohol smell exists, obtaining 300g of alcohol precipitation water extract which is used as a water phase, and storing at 4 ℃ for the next step.
3. Forming process of itching-relieving and healing-promoting cream
Formula 1: oil phase: 18g of stearic acid, 8.1g of glycerin monostearate, 32.1g of liquid paraffin, 9.9g of vaseline and 0.75g of the medicinal material volatile oil prepared in the first step; water phase: 6g of triethanolamine, 30g of glycerol and 8978 g of the alcohol precipitation water extract prepared in the second step;
and (2) formula: oil phase: 18g of stearic acid, 6g of glyceryl monostearate, 36g of liquid paraffin, 12g of vaseline and 0.2g of the medicinal material volatile oil prepared in the first step; water phase: 26.4g of glycerol and 195g of the alcohol precipitation water extract prepared in the second step;
and (3) formula: oil phase: 15g of stearic acid, 12g of glyceryl monostearate, 30g of liquid paraffin, 12g of vaseline and 0.2g of the medicinal material volatile oil prepared in the first step; water phase: 3g of span 80, 12g of Tween 80, 30g of glycerol and 185.4g of the alcohol precipitation water extract prepared in the second step;
and (4) formula: oil phase: 10g of beeswax, 10g of paraffin, 50g of liquid paraffin, 10g of vaseline and 0.75g of the medicinal material volatile oil prepared in the first step; water phase: 24g of glyceryl monostearate, 4g of span 80, 2g of Tween 80 and 100g of the ethanol precipitation water extract prepared in the second step;
and (5) formula: oil phase: 16g of paraffin, 64g of liquid paraffin, 8g of vaseline and 0.75g of the medicinal material volatile oil prepared in the first step; water phase: 16g of glyceryl monostearate, 1.6g of span 80 and 100g of alcohol precipitation water extract prepared in the second step;
and (6) formula: oil phase: 12g of beeswax, 20g of vaseline, 68g of liquid paraffin and 0.75g of the medicinal material volatile oil prepared in the first step; water phase: 8g of lanolin, 16g of glyceryl monostearate, 0.8g of Tween 80 and 100g of the ethanol precipitation water extract prepared in the second step;
and (3) formula 7: oil phase: 15g of stearic acid, 30g of hexadecanol, 15g of vaseline and 0.75g of the medicinal material volatile oil prepared in the first step; water phase: 6g of glyceryl monostearate, 9g of sodium dodecyl sulfate and 186g of the ethanol precipitation water extracting solution prepared in the second step;
and (4) formula 8: oil phase: 3g of stearic acid, 24g of hexadecanol, 30g of vaseline and 0.75g of the medicinal material volatile oil prepared in the first step; water phase: 12g of glyceryl monostearate, 6g of sodium dodecyl sulfate and 186g of the ethanol precipitation water extracting solution prepared in the second step;
and (3) formula 9: oil phase: 30g of stearic acid, 6g of lanolin, 18g of hexadecanol, 15g of vaseline and 0.75g of the medicinal material volatile oil prepared in the first step; water phase: 3g of glyceryl monostearate, 3g of sodium dodecyl sulfate and 186g of the ethanol precipitation water extracting solution prepared in the second step;
the formula 10 is as follows: oil phase: 24g of stearic acid, 6g of lanolin, 15g of hexadecanol, 6g of vaseline and 0.75g of the medicinal material volatile oil prepared in the first step; water phase: 21g of glyceryl monostearate, 3g of sodium dodecyl sulfate and 186g of the ethanol precipitation water extracting solution prepared in the second step;
the preparation method of the itching-relieving and healing-promoting cream comprises the following steps: mixing the oil phase and the water phase according to the above components, heating in 80 deg.C water bath to liquefy, mixing the two phases while hot, stirring with electric stirrer at 400rpm for 10-15min, and cooling to obtain the final product. And (5) cooling in the shade, and storing in a dry place for later use.
3.1 appearance of the cream
Selecting 10W/O matrix formulas, grading the cream matrix according to the ductility, granular feel and color of the cream, and finally selecting the formula with the highest score.
The results for the 10 formulated creams are as follows:
formula 1: the paste is moderate in thickness, white in color, fine, soft and easy to spread.
And (2) formula: the paste is thick and thin, white, yi Tu spread and has rough feel.
And (3) formula: the paste is thick, thin and white, yi Tuzhan and has a slightly granular feel.
And (4) formula 4: the paste is thick, white, not easy to spread and rough.
And (5) formula: the paste is thick and white, and Yi Tu is spread and is not easy to clean.
And (6) formula: the paste is thick and thin, white in color, yi Tuzhan, and slightly rough in spreading.
And (3) formula 7: the paste was thick, white in color Yi Tuzhan.
And (4) formula 8: the paste is thick and white, yi Tuzhan, and is difficult to clean after being spread.
Formula 9: the paste is moderate in thickness, milky white, easy to spread and not easy to clean.
Formula 10: the paste is thick and white, and the paste is slightly caked and difficult to spread.
3.2 Cold and Heat resistance test
Heat resistance test: respectively taking 5g of No. 1-10 paste, respectively filling the paste into a sealed plastic box, putting the sealed plastic box into a constant-temperature oven at 55 ℃, and observing that oil-water stratification occurs in formulas 2, 3 and 6 after 6 hours, oil-water stratification slightly occurs in formulas 7 and 8, and oil-water stratification does not occur in other formulas.
Cold resistance test: respectively taking 5g of No. 1-10 paste, respectively filling the paste into sealed plastic boxes, and placing the plastic boxes into a refrigerator at the temperature of-15 ℃ for 24 hours to observe. The cream matrix is put into a refrigerator with the temperature of-15 ℃, has no special change, and is found through comprehensive investigation: formulation 1 cream base formulation is preferred.
Example 5
Pharmacodynamic study of itching-relieving and healing-promoting cream on eczema mice
The 32 mice are randomly divided into 4 groups, each group comprises 8 mice, and the groups respectively comprise a blank group (A), a model group (B), an itching relieving and healing promoting cream group (C) and a cream matrix group (prepared by removing volatile oil from an oil phase and removing an alcohol precipitation water extract from a water phase in the formula 1) (D). Four groups of mice had their back hair removed one day before the experiment, and the eczema model was established: the mice d1 to d4 in the three groups except the blank group were subjected to skin sensitization by applying 1% DNBC-acetone olive oil solution 200. Mu.l to the back (acetone: olive oil = 3:1), the application was suspended at d5 to d8, and it was considered that the model was successfully made when the skin of the back of the mice was dry and desquamated on day 8, and the skin was maintained by applying DNBC-acetone olive oil solution 200. Mu.l daily on day 9 until the experiment was completed on day 22. And (3) drug treatment: the itching-relieving and healing-promoting cream group and the cream base group were applied with 1g of the corresponding cream 4 hours after application of 0.5% DNBC-acetone olive oil solution, starting on day 9, continuously for 14 days until day 22, and the mice were sacrificed on day 23.
1. Skin damage and scratching frequency of mice
As shown in fig. 1, fig. 1 is a schematic representation of skin lesion expression in each group of mice. A is blank group, B is model group, C is itching-relieving and healing-promoting cream group, and D is cream base group. The figure shows that the erythema, desquamation, scratch and incrustation of the model group are more serious than those of the blank group, and the erythema, desquamation, scratch and incrustation of the itching-relieving and healing-promoting cream group are improved than those of the model group; the skin damage score and scratching frequency of the model group mice are both larger than those of the blank group (p is less than 0.01); compared with the model group, the itch-relieving and heal-promoting cream group and the cream matrix group have reduced skin damage scores and scratching times (p is less than 0.05); compared with the cream matrix group, the skin damage score of the itching relieving and healing promoting cream group is reduced (p is less than 0.05), and the details are shown in a table 2.
TABLE 2 comparison of skin lesions and scratching times in mice: (
Figure BDA0003864501370000091
n=8)
Figure BDA0003864501370000092
Note: in comparison to the blank set, the data is, p is less than 0.05; in comparison to the set of models, * P<0.05
2. pathological section of mouse skin (HE staining)
As shown in fig. 2, fig. 2 is a schematic diagram of pathological sections of mice in each group. A is blank group, B is model group, C is itching-relieving and healing-promoting cream group, and D is cream base group. When the mouse skin is observed under an HE staining microscope, compared with a blank group, the model group has the defects of disordered structure of each layer of skin, hyperkeratosis of epidermis, obvious hypertrophy of a spinous layer, more inflammatory cell infiltration and disappearance of hair follicle structure; compared with a model group, the itching-relieving and healing-promoting cream group has the advantages that the structure of each layer of skin is clear, the hypertrophy of an epidermis acantho layer is reduced, a small amount of dermal blood vessels are dilated, inflammatory cells are obviously reduced, and the hair follicle structure is obviously increased; the thickness of the epidermis of the mouse in the model group is larger than that of the blank group (p < 0.01); compared with the model group, the itch-relieving and heal-promoting cream group and the cream matrix group have reduced epidermis thickness (p is less than 0.05); compared with the cream matrix group, the thickness of the epidermis of the itching relieving and healing promoting cream group is reduced (p is less than 0.05).
3. Mouse IgE levels
Serum IgE levels of the model group mice are larger than those of a blank group (p < 0.01); compared with the model group, the serum IgE level of the itching-relieving and healing-promoting cream group and the cream matrix group is reduced (p is less than 0.05), and the details are shown in a table 3.
TABLE 3 comparison of epidermal thickness and serum IgE levels in mice: (
Figure BDA0003864501370000101
n=8)
Figure BDA0003864501370000102
Although the present invention has been described with reference to a preferred embodiment, it should be understood that various changes, substitutions and alterations can be made herein without departing from the spirit and scope of the invention as defined by the appended claims.

Claims (7)

1. The traditional Chinese medicine composition for treating eczema is characterized by being prepared from the following components in parts by weight: 5 to 15 parts of golden larch bark, 5 to 15 parts of wild chrysanthemum flower, 5 to 15 parts of garden burnet root charcoal, 5 to 15 parts of wrinkled gianthyssop herb, 5 to 15 parts of oriental wormwood, 4 to 10 parts of fineleaf schizonepeta herb, 3 to 8 parts of divaricate saposhnikovia root, 3 to 8 parts of common cnidium fruit, 3 to 8 parts of mint, 1 to 5 parts of amur corktree bark, 1 to 5 parts of myrrh and 3 to 8 parts of liquorice.
2. The traditional Chinese medicine composition for treating eczema as claimed in claim 1, wherein the traditional Chinese medicine composition for treating eczema is prepared from the following components in parts by weight: 10 parts of golden larch bark, 10 parts of wild chrysanthemum flower, 10 parts of carbonized sanguisorba root, 10 parts of wrinkled gianthyssop herb, 10 parts of oriental wormwood, 7 parts of fineleaf schizonepeta herb, 5 parts of divaricate saposhnikovia root, 5 parts of common cnidium fruit, 5 parts of mint, 3 parts of amur corktree bark, 3 parts of myrrh and 5 parts of liquorice.
3. The traditional Chinese medicine composition for treating eczema as claimed in claim 1, wherein the traditional Chinese medicine composition for treating eczema is prepared from the following components in parts by weight: 15 parts of golden larch bark, 5 parts of wild chrysanthemum flower, 15 parts of carbonized sanguisorba root, 15 parts of wrinkled gianthyssop herb, 15 parts of oriental wormwood, 10 parts of fineleaf schizonepeta herb, 8 parts of divaricate saposhnikovia root, 8 parts of common cnidium fruit, 8 parts of mint, 5 parts of amur corktree bark, 5 parts of myrrh and 8 parts of liquorice.
4. The traditional Chinese medicine composition for treating eczema as claimed in claim 1, wherein the traditional Chinese medicine composition for treating eczema is prepared from the following components in parts by weight: 5 parts of golden larch bark, 15 parts of wild chrysanthemum flower, 5 parts of carbonized sanguisorba root, 5 parts of wrinkled gianthyssop herb, 5 parts of oriental wormwood, 4 parts of fineleaf schizonepeta herb, 3 parts of divaricate saposhnikovia root, 3 parts of common cnidium fruit, 3 parts of mint, 2 parts of amur corktree bark, 2 parts of myrrh and 3 parts of liquorice.
5. Use of the traditional Chinese medicine composition for treating eczema as claimed in any one of claims 1 to 4 in preparation of an itching-relieving and healing-promoting cream.
6. The use according to claim 5, wherein the preparation method of the itching-relieving and healing-promoting cream comprises the following steps:
firstly, mixing golden larch bark, wild chrysanthemum flower, carbonized sanguisorba root, wrinkled gianthyssop herb, oriental wormwood, fineleaf schizonepeta herb, divaricate saposhnikovia root, common cnidium fruit, mint, amur corktree bark, myrrh and liquoric root according to a ratio, adding 8-12 times of distilled water, decocting for 1-3 times, and 1-2 hours each time, and combining water extracts for the next step; obtaining the volatile oil of the medicinal materials;
step two, filtering the water extract obtained in the step one until the water extract is clear, adding 80% ethanol until the alcohol concentration in the water extract reaches a preset value, standing overnight at 4 ℃, filtering, and concentrating by reduced pressure distillation until no alcohol smell exists to obtain an alcohol precipitation water extract;
thirdly, the formula of the itching-relieving and healing-promoting cream is as follows: oil phase: 15 to 22g of stearic acid, 6 to 10g of glycerin monostearate, 25 to 35g of liquid paraffin, 8 to 12g of vaseline and 0.5 to 1g of the medicinal material volatile oil prepared in the first step; water phase: 4-8 g of triethanolamine, 25-35 g of glycerol and 180-210 g of alcohol precipitation water extract prepared in the second step;
according to the dosage of each component, the oil phase and the water phase are respectively mixed, the mixture is heated to be liquefied under the condition that the temperature is 75-85 ℃, the two phases are mixed while the mixture is hot, stirred for 10-15min and cooled, and the itching-relieving and healing-promoting cream is obtained.
7. The use according to claim 6, wherein the antipruritic healing promoting cream formulation is: oil phase: 18g of stearic acid, 8.1g of glyceryl monostearate, 32.1g of liquid paraffin, 9.9g of vaseline and 0.75g of the medicinal material volatile oil prepared in the first step; water phase: 6g of triethanolamine, 30g of glycerol and 8978 g of the alcohol precipitation water extract prepared in the second step.
CN202211173707.3A 2022-09-26 2022-09-26 Traditional Chinese medicine composition for treating eczema and application of traditional Chinese medicine composition in preparation of itching-relieving and healing-promoting cream Active CN115414423B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202211173707.3A CN115414423B (en) 2022-09-26 2022-09-26 Traditional Chinese medicine composition for treating eczema and application of traditional Chinese medicine composition in preparation of itching-relieving and healing-promoting cream

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202211173707.3A CN115414423B (en) 2022-09-26 2022-09-26 Traditional Chinese medicine composition for treating eczema and application of traditional Chinese medicine composition in preparation of itching-relieving and healing-promoting cream

Publications (2)

Publication Number Publication Date
CN115414423A true CN115414423A (en) 2022-12-02
CN115414423B CN115414423B (en) 2023-09-05

Family

ID=84203422

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202211173707.3A Active CN115414423B (en) 2022-09-26 2022-09-26 Traditional Chinese medicine composition for treating eczema and application of traditional Chinese medicine composition in preparation of itching-relieving and healing-promoting cream

Country Status (1)

Country Link
CN (1) CN115414423B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116832086A (en) * 2023-08-11 2023-10-03 中国人民解放军海军第九〇五医院 External traditional Chinese medicine composition for treating chapped skin and application thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104721341A (en) * 2013-12-20 2015-06-24 陕西康乐中医药养生研究院 Traditional Chinese medicine preparation for treatment of eczema
CN104840711A (en) * 2015-04-17 2015-08-19 周舜宁 Traditional Chinese medicinal composition for treating wind prevalence type acute eczema
CN107412617A (en) * 2017-08-07 2017-12-01 于瑞霞 A kind of Chinese medicine composition for treating pregnant eczema of vulva and preparation method thereof

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104721341A (en) * 2013-12-20 2015-06-24 陕西康乐中医药养生研究院 Traditional Chinese medicine preparation for treatment of eczema
CN104840711A (en) * 2015-04-17 2015-08-19 周舜宁 Traditional Chinese medicinal composition for treating wind prevalence type acute eczema
CN107412617A (en) * 2017-08-07 2017-12-01 于瑞霞 A kind of Chinese medicine composition for treating pregnant eczema of vulva and preparation method thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
范瑞强等: "肤康喷雾剂治疗皮肤病100例报告", 中医杂志, no. 12, pages 36 - 37 *
郑雄彦等: "消炎止痒喷雾剂治疗肛周湿疹48例疗效观察", 护理研究, vol. 23, no. 9, pages 2307 - 2308 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116832086A (en) * 2023-08-11 2023-10-03 中国人民解放军海军第九〇五医院 External traditional Chinese medicine composition for treating chapped skin and application thereof
CN116832086B (en) * 2023-08-11 2024-05-14 中国人民解放军海军第九〇五医院 External traditional Chinese medicine composition for treating chapped skin and application thereof

Also Published As

Publication number Publication date
CN115414423B (en) 2023-09-05

Similar Documents

Publication Publication Date Title
CN102058817B (en) Tibetan medicinal preparation for treating liver diseases
CN100455311C (en) Composition of Chinese traditional medicine in use for treating burn and scald, and product for resolving poxes, and preparation method
CN1286502C (en) Medicine for treating gout affection and its symptoms
CN115414423A (en) Traditional Chinese medicine composition for treating eczema and application of traditional Chinese medicine composition in preparation of itching-relieving and healing-promoting cream
CN104873446A (en) Cinnamon oil containing toothpaste
CN115518127B (en) Antibacterial, anti-inflammatory, detumescence and antipruritic cream and preparation method thereof
CN105999105A (en) Traditional Chinese medicine composition for treating bedsores and diabetic ulcers and preparation method thereof
CN113244356A (en) Traditional Chinese medicine composition for treating psoriasis
CN110812377B (en) Acne treatment and repair composition and application thereof
CN1233343C (en) Prescription and preparing process for compound spanishneedles ointment
CN109432211B (en) Traditional Chinese medicine composition for psoriasis and eczema, external medicine thereof, and preparation methods and application of traditional Chinese medicine composition and external medicine
CN1530122A (en) Chinese medicine for treating injury
CN115969922B (en) External traditional Chinese medicine composition for atopic dermatitis and eczema, dehumidification paste based on external traditional Chinese medicine composition and preparation method of dehumidification paste
CN101953951B (en) Hand and feed health-care and beautifying liquid and preparation method thereof
CN116870076B (en) Anti-inflammatory analgesic traditional Chinese medicine composition and preparation method and application thereof
CN1401380A (en) Anti-gout composition and preparing process thereof
CN114425061A (en) Pharmaceutical composition for treating skin pruritus caused by damp-heat accumulation
CN102370937B (en) Traditional Chinese drug composition for treating breast benign hyperplasia diseases, and preparation method thereof
EP3806878B1 (en) Herbal compositions for the treatment of urolithiasis and urinary tract infections
JP2004352680A (en) Composition for treatment of allergic disease
CN115887557A (en) Traditional Chinese medicine preparation for skin pruritus and preparation method and application thereof
CN117860819A (en) Traditional Chinese medicine composition for treating systemic sclerosis and preparation method thereof
CN117899003A (en) An ointment pharmaceutical composition for treating psoriasis
CN105477246A (en) Traditional Chinese medicine composition for treating phlegmatic hygrosis type mammary gland hyperplasia and preparation method thereof
CN105288557A (en) Medicine for treating inflammatory hyperplasia scars and keloids

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant